Scalp psoriasis: European consensus on grading and treatment algorithm.
The scalp is a common site of involvement of psoriasis and, for many patients, is a challenging aspect of their disease. This can be attributed not only to the scaling, itching and cosmetic embarrassment that go with scalp psoriasis, but also to the fact that the scalp skin is relatively inaccessible, making topical therapies difficult to apply. The proximity of sensitive facial skin can also limit the use of potentially irritating topical treatments. Nevertheless, the specific challenges of scalp psoriasis are often neglected by treatment guidelines. This paper summarizes the discussions that took place at an international conference of experts convened in Geneva, Switzerland, in March 2008. The objective of the meeting was to review the available treatments for scalp psoriasis in terms of efficacy, safety, convenience, and the implications for patient compliance with treatment. In addition, definitions of mild, moderate and severe scalp psoriasis were agreed. This paper presents a treatment algorithm that includes recommendations for patients in all three categories. It considers the role of potent topical corticosteroids, vitamin D3 derivatives, salicylic acid preparations, and photo- and radiotherapy, as well as systemic therapies, including newer biological agents, for patients with widespread psoriasis with scalp involvement. Data from clinical trials indicate that a potent topical corticosteroid in a short-contact formulation is the most appropriate treatment for most patients with scalp psoriasis.
Ortonne
Jp
J
Centre Hospitalier Universitaire de Nice, Nice, France.
Chimenti
S
S
Luger
T
T
Puig
L
L
Reid
F
F
Trüeb
R M
RM
D000465:Algorithms; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D011565:Psoriasis / Q000473:pathology* / Q000628:therapy; D012536:Scalp Dermatoses / Q000473:pathology* / Q000628:therapy
D003879:Dermatologic Agents